Immuno Cancer Biotherapeutics Form D (2026)
Immuno Cancer Biotherapeutics reported $75,000 raised in an SEC Form D filed on 2026-10-15.
- Company
- Immuno Cancer Biotherapeutics
- Round type
- Form D
- Date
- 2026-10-15
- Amount
- $75K
- Industry
- Biotechnology
- Location
- South Dakota
Summary
The SEC Form D for Immuno Cancer Biotherapeutics, filed on 2026-10-15, reports $75,000 raised. It was listed in the Raise Track Update of 2026-10-16. Filing: https://www.sec.gov/Archives/edgar/data/2158173/000215817326000001/0002158173-26-000001-index.htm
This page is not indexed by search engines yet because the filing is its only source.
Investors
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/2158173/000215817326000001/0002158173-26-000001-index.htm
Type: sec filing. Accessed 2026-10-16.
SEC Form D for Immuno Cancer Biotherapeutics, Inc. EDGAR filing date 2026-10-15. Signed 2026-10-15. First sale 2026-10-09. Total amount sold $75,000 of an indefinite offering amount. 3 investors already invested. Issuer address city is Canton, South Dakota. Jurisdiction of incorporation is Delaware. Entity type on the form is Corporation. Year of incorporation on the form: 2024. The form does not name the purchasers or a round type. Street addresses are not published. The offering amount on the form is indefinite. The amount sold is $75,000. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-16/
Type: other verified public source. Accessed 2026-10-16.
Raise Track Update for 2026-10-16, Section 3. Lists Immuno Cancer Biotherapeutics, state SOUTH DAKOTA, industry Biotechnology, amount raised $75,000.